{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:36:47Z","timestamp":1789105007369,"version":"build-2803163510"},"reference-count":186,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oral vaccines have several advantages compared with parenteral administration: they can be relatively cheap to produce in high quantities, easier to administer, and induce intestinal mucosal immunity that can protect against infection. These characteristics have led to successful use of oral vaccines against rotavirus, polio, and cholera. Unfortunately, oral vaccines for all three diseases have demonstrated lower performance in the highest-burden settings where they are most needed. Rotavirus vaccines are estimated to have &amp;gt;85% effectiveness against hospitalization in children &amp;lt;12 months in countries with low child mortality, but only ~65% effectiveness in countries with high child mortality. Similarly, oral polio vaccines have lower immunogenicity in developing country settings compared with high-resource settings. Data are more limited for oral cholera vaccines, but suggest lower titers among children compared with adults, and, for some vaccines, lower efficacy in endemic settings compared with non-endemic settings. These disparities are likely multifactorial, and available evidence suggests a role for maternal factors (e.g. transplacental antibodies, breastmilk), host factors (e.g. genetic polymorphisms\u2014with the best evidence for rotavirus\u2014or previous infection), and environmental factors (e.g. gut microbiome, co-infections). Overall, these data highlight the rather ambiguous and often contradictory nature of evidence on factors affecting oral vaccine response, cautioning against broad extrapolation of outcomes based on one population or one vaccine type. Meaningful impact on performance of oral vaccines will likely only be possible with a suite of interventions, given the complex and multifactorial nature of the problem, and the degree to which contributing factors are intertwined.<\/jats:p>","DOI":"10.1093\/cei\/uxae124","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T23:29:57Z","timestamp":1734737397000},"source":"Crossref","is-referenced-by-count":9,"title":["Geographic disparities impacting oral vaccine performance: Observations and future directions"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-5826","authenticated-orcid":false,"given":"Rachel M","family":"Burke","sequence":"first","affiliation":[{"name":"Global Development Division, Bill & Melinda Gates Foundation , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-8534","authenticated-orcid":false,"given":"Sasirekha","family":"Ramani","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[{"name":"Office of the Director General, International Vaccine Institute , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura V","family":"Cooper","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haeun","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Data Science and Innovation, International Vaccine Institute , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda S","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"Global Development Division, Bill & Melinda Gates Foundation , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Global Health Division, Bill & Melinda Gates Foundation , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Duncan","family":"Steele","sequence":"additional","affiliation":[{"name":"Global Health Division, Bill & Melinda Gates Foundation , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[{"name":"Global Health Division, Bill & Melinda Gates Foundation , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2026031913320115300_CIT0001","author":"World Health Organization"},{"key":"2026031913320115300_CIT0002","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2217\/fmb-2017-0128","article-title":"Causes of impaired oral vaccine efficacy in developing countries","volume":"13","author":"Parker","year":"2018","journal-title":"Future Microbiol"},{"key":"2026031913320115300_CIT0003","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"2026031913320115300_CIT0004","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1093\/infdis\/jiaa622","article-title":"Immunization against poliomyelitis and the challenges to worldwide poliomyelitis eradication","volume":"224","author":"Modlin","year":"2021","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0005","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2023.10.005","article-title":"Estimating the global impact of rotavirus vaccines on child mortality","volume":"137","author":"Clark","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2026031913320115300_CIT0006","doi-asserted-by":"publisher","first-page":"e1003003","DOI":"10.1371\/journal.pmed.1003003","article-title":"The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: a modeling study","volume":"16","author":"Lee","year":"2019","journal-title":"PLoS Med"},{"key":"2026031913320115300_CIT0007","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1080\/21645515.2018.1504155","article-title":"Oral cholera vaccines and their impact on the global burden of disease","volume":"15","author":"Wierzba","year":"2019","journal-title":"Human Vaccin Immunother"},{"key":"2026031913320115300_CIT0008","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2026031913320115300_CIT0009","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children &lt;5 years of age, 2000-2013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0010","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2214-109X(24)00078-0","article-title":"Estimated global and regional causes of deaths from diarrhoea in children younger than 5 years during 2000-21: a systematic review and Bayesian multinomial analysis","volume":"12","author":"Black","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026031913320115300_CIT0011","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/s0140-6736(73)92867-5","article-title":"Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis","volume":"2","author":"Bishop","year":"1973","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0012","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0140-6736(74)92440-4","article-title":"Detection of a new virus by electron microscopy of faecal extracts from children with acute gastroenteritis","volume":"1","author":"Bishop","year":"1974","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0013","first-page":"1917","article-title":"Rotaviruses","volume-title":"Fields Virology","author":"Estes","year":"2007"},{"key":"2026031913320115300_CIT0014","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1126\/science.272.5258.101","article-title":"Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein","volume":"272","author":"Ball","year":"1996","journal-title":"Science"},{"key":"2026031913320115300_CIT0015","doi-asserted-by":"publisher","first-page":"17083","DOI":"10.1038\/nrdp.2017.83","article-title":"Rotavirus infection","volume":"3","author":"Crawford","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026031913320115300_CIT0016","doi-asserted-by":"publisher","first-page":"e1002115","DOI":"10.1371\/journal.ppat.1002115","article-title":"Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting","volume":"7","author":"Hagbom","year":"2011","journal-title":"PLoS Pathog"},{"key":"2026031913320115300_CIT0017","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/IDR.S186404","article-title":"Rotavirus infection beyond the gut","volume":"12","author":"Gomez-Rial","year":"2019","journal-title":"Infect Drug Resist"},{"key":"2026031913320115300_CIT0018","doi-asserted-by":"publisher","first-page":"441","DOI":"10.15585\/mmwr.mm7319a4","article-title":"Progress toward poliomyelitis eradication - Worldwide, January 2022-December 2023","volume":"73","author":"Geiger","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026031913320115300_CIT0019","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"2026031913320115300_CIT0020","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virol.2005.09.015","article-title":"One hundred years of poliovirus pathogenesis","volume":"344","author":"Racaniello","year":"2006","journal-title":"Virology"},{"key":"2026031913320115300_CIT0021","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fmicb.2012.00147","article-title":"Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway","volume":"3","author":"Ohka","year":"2012","journal-title":"Front Microbiol"},{"key":"2026031913320115300_CIT0022","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"2026031913320115300_CIT0023","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/tropicalmed8030169","article-title":"Global patterns of trends in cholera mortality","volume":"8","author":"Ilic","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"2026031913320115300_CIT0024"},{"key":"2026031913320115300_CIT0025","author":"World Health Organization Emergency Response Team"},{"key":"2026031913320115300_CIT0026","doi-asserted-by":"publisher","first-page":"e0021121","DOI":"10.1128\/cmr.00211-21","article-title":"Diagnosis, management, and future control of cholera","volume":"35","author":"Chowdhury","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"2026031913320115300_CIT0027","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJMp1013771","article-title":"Antibiotics for both moderate and severe cholera","volume":"364","author":"Nelson","year":"2011","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0028","doi-asserted-by":"publisher","first-page":"1155751","DOI":"10.3389\/fmed.2023.1155751","article-title":"Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development","volume":"10","author":"Montero","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026031913320115300_CIT0029","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"Kanungo","year":"2022","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0030","doi-asserted-by":"publisher","first-page":"e00597","DOI":"10.1128\/mSphere.00597-19","article-title":"Vibrio cholerae at the intersection of immunity and the microbiome","volume":"4","author":"Weil","year":"2019","journal-title":"mSphere"},{"key":"2026031913320115300_CIT0031","doi-asserted-by":"publisher","first-page":"S732","DOI":"10.1093\/infdis\/jiab497","article-title":"Correlates of protection for cholera","volume":"224","author":"Iyer","year":"2021","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0032","author":"International Vaccine Access Center","year":"2020","journal-title":"Current and upcoming rotavirus vaccines"},{"key":"2026031913320115300_CIT0033","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/14712598.2021.1977279","article-title":"Rotavirus vaccines: progress and new developments","volume":"22","author":"Cates","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"2026031913320115300_CIT0034","author":"World Health Organization","journal-title":"Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)"},{"key":"2026031913320115300_CIT0035","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/jpids\/piab114","article-title":"Global Estimates of Rotavirus Hospitalizations Among Children Below 5 Years in 2019 and Current and Projected Impacts of Rotavirus Vaccination","volume":"11","author":"Hallowell","year":"2021","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"2026031913320115300_CIT0036","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0037","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0038","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0039","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0040","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0041","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0042","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0043","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0044","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1016\/S2214-109X(20)30262-X","article-title":"Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis","volume":"8","author":"Burnett","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026031913320115300_CIT0045","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/infdis\/jiaa081","article-title":"Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children 5 years old: 2006\u20132019","volume":"222","author":"Burnett","year":"2020","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0046","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0047","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/pathogens13040273","article-title":"Novel oral polio vaccine Type 2 use for polio outbreak response: a global effort for a global health emergency","volume":"13","author":"Kurji","year":"2024","journal-title":"Pathogens"},{"key":"2026031913320115300_CIT0048","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-023-06212-3","article-title":"Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3","volume":"619","author":"Yeh","year":"2023","journal-title":"Nature"},{"key":"2026031913320115300_CIT0049","article-title":"Monitoring the risk of Type-2 circulating vaccine-derived poliovirus emergence during roll-out of Type-2 novel oral polio vaccine","author":"Peak","year":"2023"},{"key":"2026031913320115300_CIT0050","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"2026031913320115300_CIT0051","first-page":"61","volume-title":"Geographic Variation in Vaccine Efficacy: The Polio Experience","author":"John","year":"1989"},{"key":"2026031913320115300_CIT0052","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","article-title":"Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines","volume":"128","author":"McBean","year":"1988","journal-title":"Am J Epidemiol"},{"key":"2026031913320115300_CIT0053","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S1473-3099(19)30301-9","article-title":"Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis","volume":"19","author":"Macklin","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0054","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication","volume":"33","author":"Caceres","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0055","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/infdis\/jiaa704","article-title":"Immunogenicity of reduced-dose monovalent Type 2 oral poliovirus vaccine in Mocuba, Mozambique","volume":"226","author":"de Deus","year":"2022","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0056","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(23)02844-1","article-title":"Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to &lt;5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial","volume":"403","author":"Ochoge","year":"2024","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0057","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(20)32540-X","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials","volume":"397","author":"Saez-Llorens","year":"2021","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0058","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S1473-3099(23)00139-1","article-title":"Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial","volume":"23","author":"Wilkinson","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0059","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0140-6736(22)02397-2","article-title":"Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial","volume":"401","author":"Zaman","year":"2023","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0060","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1473-3099(23)00519-4","article-title":"Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic","volume":"24","author":"Rivera Mejia","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0061","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0062","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1016\/S2214-109X(13)70168-2","article-title":"Key issues in the persistence of poliomyelitis in Nigeria: a case-control study","volume":"2","author":"Mangal","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2026031913320115300_CIT0063","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0064","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0065","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0066","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0067","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea","volume":"29","author":"Baik","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2026031913320115300_CIT0068","volume-title":"Immunogenicity of the Bivalent Killed, Whole-Cell, Oral Cholera Vaccine: A Meta-analysis","author":"Kim","year":"2017"},{"key":"2026031913320115300_CIT0069","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0070","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.vaccine.2021.12.015","article-title":"A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh","volume":"40","author":"Chowdhury","year":"2022","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0071","doi-asserted-by":"publisher","first-page":"e826","DOI":"10.1016\/S2214-109X(24)00059-7","article-title":"Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial","volume":"12","author":"Song","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026031913320115300_CIT0072","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/tmi.12641","article-title":"Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings","volume":"21","author":"Desai","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2026031913320115300_CIT0073","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/s0264-410x(98)00098-x","article-title":"Infant B cell responses to polysaccharide determinants","volume":"16","author":"Rijkers","year":"1998","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0074","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1128\/iai.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect Immun"},{"key":"2026031913320115300_CIT0075","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0076","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0077","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0078","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1086\/315462","article-title":"Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru","volume":"181","author":"Taylor","year":"2000","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0079","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"2026031913320115300_CIT0080","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0081","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0923-2508(90)90128-d","article-title":"Recombinant attenuated Vibrio cholerae strains used as live oral vaccines","volume":"141","author":"Kaper","year":"1990","journal-title":"Res Microbiol"},{"key":"2026031913320115300_CIT0082","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"key":"2026031913320115300_CIT0083","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0084","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"2026031913320115300_CIT0085","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak","volume":"22","author":"Calain","year":"2004","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0086","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/s0264-410x(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0087","doi-asserted-by":"publisher","first-page":"e1009010","DOI":"10.1371\/journal.ppat.1009010","article-title":"Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries","volume":"16","author":"Otero","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026031913320115300_CIT0088","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/INF.0000000000000481","article-title":"Rotavirus-specific IgG antibodies from mothers\u2019 serum may inhibit infant immune responses to the pentavalent rotavirus vaccine","volume":"34","author":"Becker-Dreps","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0089","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.vaccine.2013.12.017","article-title":"Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants","volume":"32","author":"Appaiahgari","year":"2014","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0090","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/cid\/civ828","article-title":"Prevaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants","volume":"62","author":"Moon","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0091","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.vaccine.2010.11.087","article-title":"Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries","volume":"29","author":"Chan","year":"2011","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0092","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1542\/peds.31.4.641","article-title":"Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth","volume":"31","author":"Sabin","year":"1963","journal-title":"Pediatrics"},{"key":"2026031913320115300_CIT0093","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1542\/peds.34.1.4","article-title":"The relationship of maternal antibody, breast feeding, and age to the susceptibility of newborn infants to infection with attenuated polioviruses","volume":"34","author":"Warren","year":"1964","journal-title":"Pediatrics"},{"key":"2026031913320115300_CIT0094","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1473-3099(15)00094-8","article-title":"Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial","volume":"15","author":"Estivariz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0095","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"Asturias","year":"2007","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0096","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.vaccine.2021.12.007","article-title":"The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis","volume":"40","author":"Oguti","year":"2022","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0097","doi-asserted-by":"publisher","first-page":"ofx066","DOI":"10.1093\/ofid\/ofx066","article-title":"Rotavirus vaccine schedules and vaccine response among infants in low- and middle-income countries: a systematic review","volume":"4","author":"Gruber","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2026031913320115300_CIT0098","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/cid\/ciw346","article-title":"Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial","volume":"63","author":"Colgate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0099","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1080\/21645515.2020.1844525","article-title":"Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines","volume":"17","author":"Lee","year":"2021","journal-title":"Human Vaccin Immunother"},{"key":"2026031913320115300_CIT0100","doi-asserted-by":"publisher","first-page":"104796","DOI":"10.1016\/j.cellimm.2023.104796","article-title":"Maternal immune factors involved in the prevention or facilitation of neonatal bacterial infections","volume":"395-396","author":"Sereme","year":"2024","journal-title":"Cell Immunol"},{"key":"2026031913320115300_CIT0101","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","article-title":"Human milk composition: nutrients and bioactive factors","volume":"60","author":"Ballard","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"2026031913320115300_CIT0102","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/cdli.11.1.186-194.2004","article-title":"Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers","volume":"11","author":"Ray","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"2026031913320115300_CIT0103","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-1-4615-3838-7_35","article-title":"Rotavirus specific breast milk antibody in two populations and possible correlates of protection","volume":"310","author":"Losonsky","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"2026031913320115300_CIT0104","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/jcm.31.3.593-597.1993","article-title":"Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life","volume":"31","author":"Brussow","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2026031913320115300_CIT0105","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/INF.0b013e3181e232ea","article-title":"Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines","volume":"29","author":"Moon","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0106","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/INF.0b013e318290646d","article-title":"Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries","volume":"32","author":"Moon","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0107","doi-asserted-by":"publisher","first-page":"e0150100","DOI":"10.1371\/journal.pone.0150100","article-title":"Association of maternal immunity with rotavirus vaccine immunogenicity in Zambian infants","volume":"11","author":"Chilengi","year":"2016","journal-title":"PLoS One"},{"key":"2026031913320115300_CIT0108","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.4161\/21645515.2014.980204","article-title":"Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines","volume":"10","author":"Trang","year":"2014","journal-title":"Human Vaccin Immunother"},{"key":"2026031913320115300_CIT0109","doi-asserted-by":"publisher","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","article-title":"Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants","volume":"32","author":"Rongsen-Chandola","year":"2014","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0110","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2471\/BLT.13.128066","article-title":"Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa","volume":"92","author":"Groome","year":"2014","journal-title":"Bull World Health Organ"},{"key":"2026031913320115300_CIT0111","doi-asserted-by":"publisher","first-page":"e0127622","DOI":"10.1371\/journal.pone.0127622","article-title":"Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"2026031913320115300_CIT0112","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1038\/s41467-021-27074-1","article-title":"Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants","volume":"12","author":"Parker","year":"2021","journal-title":"Nat Commun"},{"key":"2026031913320115300_CIT0113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archpedi.1966.02090040063004","article-title":"Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding","volume":"111","author":"Plotkin","year":"1966","journal-title":"Am J Dis Child"},{"key":"2026031913320115300_CIT0114","first-page":"333","article-title":"Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda","volume":"51","author":"Domok","year":"1974","journal-title":"Bull World Health Organ"},{"key":"2026031913320115300_CIT0115","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.vaccine.2018.05.080","article-title":"Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies","volume":"37","author":"Pan","year":"2019","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0116","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","article-title":"Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh","volume":"2","author":"Naylor","year":"2015","journal-title":"eBioMedicine"},{"key":"2026031913320115300_CIT0117","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.vaccine.2013.11.056","article-title":"Oral polio vaccine response in breast fed infants with malnutrition and diarrhea","volume":"32","author":"Haque","year":"2014","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0118","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0119","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jpids\/piv076","article-title":"Innate immune factors in mothers\u2019 breast milk and their lack of association with rotavirus vaccine immunogenicity in Nicaraguan Infants","volume":"6","author":"Becker-Dreps","year":"2017","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"2026031913320115300_CIT0120","doi-asserted-by":"publisher","first-page":"e0189351","DOI":"10.1371\/journal.pone.0189351","article-title":"Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia","volume":"12","author":"Mwila-Kazimbaya","year":"2017","journal-title":"PLoS One"},{"key":"2026031913320115300_CIT0121","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/s41467-018-07476-4","article-title":"Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection","volume":"9","author":"Ramani","year":"2018","journal-title":"Nat Commun"},{"key":"2026031913320115300_CIT0122","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/ajcn\/nqab336","article-title":"Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial","volume":"115","author":"Estorninos","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"2026031913320115300_CIT0123","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/v13061144","article-title":"Effect of infant and maternal secretor status on rotavirus vaccine take-an overview","volume":"13","author":"Sharma","year":"2021","journal-title":"Viruses"},{"key":"2026031913320115300_CIT0124","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jiae055","article-title":"Correlates of rotavirus vaccine shedding and seroconversion in a U.S. cohort of healthy infants","volume":"230","author":"Burke","year":"2024","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0125","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1016\/j.vaccine.2023.05.007","article-title":"Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination","volume":"41","author":"Middleton","year":"2023","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0126","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1016\/j.vaccine.2020.11.025","article-title":"Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa","volume":"38","author":"Magwira","year":"2020","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0127","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/infdis\/jiy573","article-title":"Rotavirus vaccine take in infants is associated with secretor status","volume":"219","author":"Armah","year":"2019","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0128","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/infdis\/jix028","article-title":"Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants","volume":"215","author":"Kazi","year":"2017","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0129","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1038\/s41598-020-64025-0","article-title":"Rotavirus A shedding and HBGA host genetic susceptibility in a birth community-cohort, Rio de Janeiro, Brazil, 2014-2018","volume":"10","author":"Cantelli","year":"2020","journal-title":"Sci Rep"},{"key":"2026031913320115300_CIT0130","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/cid\/ciy1067","article-title":"Nonsecretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants","volume":"69","author":"Pollock","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0131","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41598-018-19718-y","article-title":"The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children","volume":"8","author":"Bucardo","year":"2018","journal-title":"Sci Rep"},{"key":"2026031913320115300_CIT0132","doi-asserted-by":"publisher","first-page":"10764","DOI":"10.1038\/s41598-019-47166-9","article-title":"Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants","volume":"9","author":"Bucardo","year":"2019","journal-title":"Sci Rep"},{"key":"2026031913320115300_CIT0133","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.pathol.2022.04.006","article-title":"Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants","volume":"54","author":"El-Heneidy","year":"2022","journal-title":"Pathology (Phila)"},{"key":"2026031913320115300_CIT0134","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/infdis\/jiaa101","article-title":"Maternal secretor status affects oral rotavirus vaccine response in breastfed infants in Bangladesh","volume":"224","author":"Williams","year":"2021","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0135","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/infdis\/jiy553","article-title":"FUT2 secretor status is not associated with oral poliovirus vaccine immunogenicity in South Indian infants","volume":"219","author":"Parker","year":"2019","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0136","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12889-023-15051-w","article-title":"Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia","volume":"23","author":"Chisenga","year":"2023","journal-title":"BMC Public Health"},{"key":"2026031913320115300_CIT0137","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1128\/CVI.00123-10","article-title":"A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response","volume":"17","author":"Ramamurthy","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2026031913320115300_CIT0138","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/iai.63.2.707-709.1995","article-title":"Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O","volume":"63","author":"Lagos","year":"1995","journal-title":"Infect Immun"},{"key":"2026031913320115300_CIT0139","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","article-title":"ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy","volume":"159","author":"Clemens","year":"1989","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0140","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3389\/fmicb.2019.01495","article-title":"Host genetics, innate immune responses, and cellular death pathways in poliomyelitis patients","volume":"10","author":"Andersen","year":"2019","journal-title":"Front Microbiol"},{"key":"2026031913320115300_CIT0141","doi-asserted-by":"publisher","first-page":"192ra86","DOI":"10.1126\/scitranslmed.3006338","article-title":"Natural selection in a Bangladeshi population from the cholera-endemic Ganges river delta","volume":"5","author":"Karlsson","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026031913320115300_CIT0142","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/INF.0000000000003206","article-title":"Rotavirus infection, illness, and vaccine performance in malnourished children: a review of the literature","volume":"40","author":"Burnett","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0143","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1093\/infdis\/jit492","article-title":"Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India","volume":"210","author":"Bahl","year":"2014","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0144","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.vaccine.2015.04.055","article-title":"Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan","volume":"33","author":"Saleem","year":"2015","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0145","doi-asserted-by":"publisher","first-page":"e0005039","DOI":"10.1371\/journal.pntd.0005039","article-title":"Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children","volume":"10","author":"Uddin","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"key":"2026031913320115300_CIT0146","first-page":"105","article-title":"Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine","volume":"8","author":"Glass","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0147","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(18)30602-9","article-title":"Interventions to improve oral vaccine performance: a systematic review and meta-analysis","volume":"19","author":"Church","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026031913320115300_CIT0148","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/trstmh\/try126","article-title":"Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants","volume":"113","author":"Church","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2026031913320115300_CIT0149","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vaccine.2020.10.048","article-title":"Evaluating association of vaccine response to low serum zinc and vitamin D levels in children of a birth cohort study in Dhaka","volume":"39","author":"Das","year":"2021","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0150","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.vaccine.2017.07.116","article-title":"The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants","volume":"36","author":"Lazarus","year":"2018","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0151","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.vaccine.2014.12.001","article-title":"Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial","volume":"33","author":"Habib","year":"2015","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0152","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0153","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1128\/IAI.71.7.3909-3913.2003","article-title":"Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation","volume":"71","author":"Karlsen","year":"2003","journal-title":"Infect Immun"},{"key":"2026031913320115300_CIT0154","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/INF.0000000000001457","article-title":"The association between fecal biomarkers of environmental enteropathy and rotavirus vaccine response in Nicaraguan infants","volume":"36","author":"Becker-Dreps","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2026031913320115300_CIT0155","doi-asserted-by":"publisher","first-page":"e0293101","DOI":"10.1371\/journal.pone.0293101","article-title":"Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach","volume":"18","author":"Mwila-Kazimbaya","year":"2023","journal-title":"PLoS One"},{"key":"2026031913320115300_CIT0156","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4269\/ajtmh.16-0037","article-title":"Plasma tryptophan and the kynurenine-tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy","volume":"95","author":"Kosek","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2026031913320115300_CIT0157","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1086\/315051","article-title":"Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR","volume":"180","author":"Lagos","year":"1999","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0158","doi-asserted-by":"publisher","first-page":"e0187761","DOI":"10.1371\/journal.pone.0187761","article-title":"Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction","volume":"12","author":"Mwape","year":"2017","journal-title":"PLoS One"},{"key":"2026031913320115300_CIT0159","doi-asserted-by":"publisher","first-page":"101173","DOI":"10.1016\/j.eclinm.2021.101173","article-title":"Associations between biomarkers of environmental enteric dysfunction and oral rotavirus vaccine immunogenicity in rural Zimbabwean infants","volume":"41","author":"Church","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2026031913320115300_CIT0160","doi-asserted-by":"publisher","first-page":"e1003005","DOI":"10.1371\/journal.pmed.1003005","article-title":"Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: a secondary, pooled analysis of Phase II and III trial data from 33 countries","volume":"16","author":"Baker","year":"2019","journal-title":"PLoS Med"},{"key":"2026031913320115300_CIT0161","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cid\/civ807","article-title":"Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh","volume":"62","author":"Emperador","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0162","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1016\/j.vaccine.2008.08.034","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2010","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0163","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/21645515.2015.1085143","article-title":"Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants","volume":"12","author":"Li","year":"2016","journal-title":"Human Vaccin Immunother"},{"key":"2026031913320115300_CIT0164","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0165","doi-asserted-by":"publisher","first-page":"A30","DOI":"10.1016\/j.vaccine.2011.11.093","article-title":"Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines","volume":"30","author":"Patel","year":"2012","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0166","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1016\/j.vaccine.2019.09.071","article-title":"Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)","volume":"37","author":"Cowley","year":"2019","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0167","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.vaccine.2019.02.018","article-title":"Immunogenicity of pentavalent rotavirus vaccine in Chinese infants","volume":"37","author":"Mo","year":"2019","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0168","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1016\/j.vaccine.2018.07.064","article-title":"Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL\u00ae with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine","volume":"36","author":"Desai","year":"2018","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0169","doi-asserted-by":"publisher","first-page":"e00302","DOI":"10.1016\/j.heliyon.2017.e00302","article-title":"ROTAVAC((R)) does not interfere with the immune response to childhood vaccines in Indian infants: a randomized placebo controlled trial","volume":"3","author":"Chandola","year":"2017","journal-title":"Heliyon"},{"key":"2026031913320115300_CIT0170","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/cid\/ciac782","article-title":"Co-administration of oral cholera vaccine with oral polio vaccine among Bangladeshi young children: a randomized controlled open label trial to assess interference","volume":"76","author":"Islam","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0171","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","article-title":"Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants","volume":"34","author":"Taniuchi","year":"2016","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0172","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.chom.2021.12.002","article-title":"Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants","volume":"30","author":"Kim","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2026031913320115300_CIT0173","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/jiu182","article-title":"Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis","volume":"210","author":"Parker","year":"2014","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0174","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/infdis\/jiy568","article-title":"Influence of nonpolio enteroviruses and the bacterial gut microbiota on oral poliovirus vaccine response: a study from South India","volume":"219","author":"Praharaj","year":"2019","journal-title":"J Infect Dis"},{"key":"2026031913320115300_CIT0175","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/19490976.2017.1376162","article-title":"Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan","volume":"9","author":"Harris","year":"2018","journal-title":"Gut Microbes"},{"key":"2026031913320115300_CIT0176","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.vaccine.2017.11.031","article-title":"Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India","volume":"36","author":"Parker","year":"2018","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0177","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1542\/peds.2013-3937","article-title":"Stool microbiota and vaccine responses of infants","volume":"134","author":"Huda","year":"2014","journal-title":"Pediatrics"},{"key":"2026031913320115300_CIT0178","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41541-020-0194-5","article-title":"Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine","volume":"5","author":"Zhao","year":"2020","journal-title":"npj Vaccines"},{"key":"2026031913320115300_CIT0179","doi-asserted-by":"publisher","first-page":"15392","DOI":"10.1038\/s41598-020-71791-4","article-title":"Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"key":"2026031913320115300_CIT0180","doi-asserted-by":"publisher","first-page":"e0021721","DOI":"10.1128\/IAI.00217-21","article-title":"Gut microbiota and development of Vibrio cholerae-specific long-term memory B cells in adults after whole-cell killed oral cholera vaccine","volume":"89","author":"Chac","year":"2021","journal-title":"Infect Immun"},{"key":"2026031913320115300_CIT0181","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1371\/journal.pntd.0000403","article-title":"Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh","volume":"3","author":"Harris","year":"2009","journal-title":"PLoS NeglTrop Dis"},{"key":"2026031913320115300_CIT0182","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.vaccine.2019.09.088","article-title":"The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: a double-blind, parallel group, randomized, controlled trial","volume":"38","author":"Lee","year":"2020","journal-title":"Vaccine"},{"key":"2026031913320115300_CIT0183","doi-asserted-by":"publisher","first-page":"101687","DOI":"10.1016\/j.eclinm.2022.101687","article-title":"Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children","volume":"54","author":"Middleton","year":"2022","journal-title":"eClinicalMedicine"},{"key":"2026031913320115300_CIT0184","first-page":"145","article-title":"Polio vaccines: WHO position paper \u2013 March, 2016 = Note de synth\u00e8se de l\u2019OMS sur les vaccins antipoliomy\u00e9litiques \u2013 mars 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Weekly Epidemiol Record"},{"key":"2026031913320115300_CIT0185","doi-asserted-by":"publisher","first-page":"e1150","DOI":"10.1093\/cid\/ciac699","article-title":"Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III Trial Data","volume":"76","author":"Amin","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026031913320115300_CIT0186","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/INF.0000000000003286","article-title":"Do rotavirus strains affect vaccine effectiveness? A systematic review and meta-analysis","volume":"40","author":"Cates","year":"2021","journal-title":"Pediatr Infect Dis J"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxae124\/61379958\/uxae124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxae124\/61379958\/uxae124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxae124\/61379958\/uxae124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:32:11Z","timestamp":1773941531000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxae124\/7945489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":186,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxae124","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxae124"}}